Its active ingredient called curcumin has antioxidant, anti-inflammatory and bone-building capabilities. It has also been shown to prevent various forms of cancers.
However, the compound can’t be absorbed well in the body when taken orally. This is because it is metabolized too quickly.
In a recent study from Washington State University, researchers found that turmeric may help stop cancer cell growth.
They developed a drug delivery system using curcumin, the main ingredient in turmeric, that successfully inhibits bone cancer cells while helping with the growth of healthy bone cells.
The findings may lead to better postoperative treatments for people with a bone cancer called osteosarcoma.
The study is published in the journal ACS Applied Materials and Interfaces. One author is Susmita Bose in the Department of Chemistry.
Young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery. But the chemotherapy often has many harmful side effects.
Therefore, it is important to develop gentler treatment options to help patients recover from bone damage while suppressing tumor growth.
In the study, the team used 3-D printing to build support scaffolds out of calcium phosphate.
They incorporated curcumin, encapsulated in a vesicle of fat molecules into the scaffolds, allowing for the gradual release of the chemical.
They found that this drug delivery system could reduce the growth of bone cancer cells by 96% after 11 days as compared to untreated samples. The system also promoted healthy bone cell growth.
The team says the study introduces a new era of integration and may provide a better tool for bone tissue engineering.
They now are continuing the research and examining the benefits of integrating other natural compounds in biomedical technology.
Copyright © 2019 Knowridge Science Report. All rights reserved.
